aluminum sulfate has been researched along with Chickungunya Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arévalo, MT; Huang, Y; Jones, CA; Ross, TM | 1 |
| Arankalle, VA; Kumar, M; Sudeep, AB | 1 |
2 other study(ies) available for aluminum sulfate and Chickungunya Fever
| Article | Year |
|---|---|
Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice.
Topics: Adjuvants, Immunologic; Age Factors; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chikungunya Fever; Chikungunya virus; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunoglobulin G; Injections, Intramuscular; Mice, Inbred C57BL; Vaccines, Virus-Like Particle; Viral Vaccines | 2019 |
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Topics: Adjuvants, Immunologic; Alphavirus Infections; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chikungunya Fever; Chikungunya virus; Chlorocebus aethiops; Cross Reactions; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Humoral; Mice; Mice, Inbred BALB C; Neutralization Tests; Recombinant Proteins; Vaccines, Inactivated; Vaccines, Synthetic; Vero Cells; Viral Envelope Proteins; Viral Vaccines | 2012 |